TABLE 2.
ApoB-containing lipoprotein subclasses in patients with β-thalassemia and the control group
Control | β-TI | β-TM | |
---|---|---|---|
Parameter | |||
VLDL-cholesterol, mmol/l | 1.2 ± 0.2 | 1.6 ± 0.3a | 1.7 ± 0.3a |
IDL-cholesterol, mmol/l | 1.7 ± 0.3 | 1.3 ± 0.2a | 1.2 ± 0.3a |
Buoyant LDL-cholesterol, mmol/l | 3.6 ± 0.7 | 2.8 ± 0.8a | 2.6 ± 0.9a |
sdLDL-cholesterol, mmol/l | 0.20 ± 0.08 | 0.43 ± 0.10b | 0.52 ± 0.30b |
sdLDL proportion, % | 3.6 ± 0.9 | 9.5 ± 2.1b | 12.0 ± 4.1b |
Mean LDL size, Å | 269 ± 4 | 259 ± 3b | 258 ± 4b |
Data represent the mean ± SD values. IDL, intermediate density lipoprotein; LDL, low density lipoprotein, sdLDL, small dense LDL; VLDL, very low density lipoprotein.
P < 0.01 compared with control values.
P < 0.001 compared with control values.